Cary Street Partners Investment Advisory LLC Eli Lilly & CO Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

A detailed history of Cary Street Partners Investment Advisory LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 25,826 shares of LLY stock, worth $20.1 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

25,826

Previous 25,841 0.06%

Holding current value

$20.1 Million

Previous $23.4 Million 2.2%

% of portfolio

0.87%

Previous 0.97%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 0.06%	25,826 $22.9 Million
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $289,948 - $363,616	-400 Reduced 1.52%	25,841 $23.4 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $307,351 - $411,193	-519 Reduced 1.94%	26,241 $20.4 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $9.53 Million - $11.2 Million	18,145 Added 210.62%	26,760 $15.6 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $9.15 Million - $10.8 Million	-17,414 Reduced 66.9%	8,615 $5.02 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $136,930 - $188,779	315 Added 1.23%	26,029 $14 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $543,647 - $726,919	-1,550 Reduced 5.69%	25,714 $12.1 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $180,786 - $212,325	-582 Reduced 2.09%	27,264 $9.36 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $257,240 - $299,736	-800 Reduced 2.79%	27,846 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $555,010 - $632,492	1,872 Added 6.99%	28,646 $9.26 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $4.93 Million - $5.78 Million	17,676 Added 194.28%	26,774 $8.68 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $113,355 - $140,871	483 Added 5.61%	9,098 $2.61 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $76,449 - $94,873	340 Added 4.11%	8,615 $2.38 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $23,711 - $29,179	-107 Reduced 1.28%	8,275 $1.91 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $364,711 - $471,750	2,020 Added 31.75%	8,382 $1.92 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $867,445 - $1.12 Million	-5,279 Reduced 45.35%	6,362 $1.19 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $654,909 - $866,602	5,020 Added 75.82%	11,641 $1.97 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $968,122 - $1.12 Million	6,621 New	6,621 $980,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account

Cary Street Partners Investment Advisory LLC Eli Lilly & CO Transaction History